Publications

5674 Results

Comparison of bilateral orchiectomy with or without flutamide for the treatment of patients (pts) with stage D2 adenocarcinoma of the prostate (CaP): Results of NCI Intergroup study 0105 (SWOG and ECOG).

Authors
ED Crawford;MA Eisenberger;DG McLeod;G Wilding;BA Blumenstein
Journal / Conference
Journal of Urology 157(4):336(#1311)
Year
1997
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8894 (INT-0105) (EST-2889)

A phase II trial of intravenous vinorelbine in previously untreated patients with extensive small cell lung cancer, a Southwest Oncology Group study.

Authors
CS Higano;JJ Crowley;RV Veith;RB Livingston
Journal / Conference
Investigational New Drugs 15:153-156
Year
1997
Research Committee(s)
Lung
Study Number(s)
SWOG-9058

Immunologic reconstitution following adjuvant 5FU and levamisole (LMS) correlates with disease free survival in stage III colon cancer: Report of Southwest Oncology Group (SWOG) protocol #9009.

Authors
RF Holcombe;J Jacobson;JS Macdonald;SR Dakhil;RM Stewart;KS Betzing;K Kannan
Journal / Conference
Proc of the American Association for Cancer Research 38:521(#3494)
Year
1997
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9009

Megestrol acetate and aminoglutethimide/hydrocortisone in sequence or in combination as second-line endocrine therapy of estrogen receptor positive metastatic breast cancer: A Southwest Oncology Group phase III trial.

Authors
CA Russell;SJ Green;J O'Sullivan;HE Hynes;GT Budd;JE Congdon;S Martino;CK Osborne
Journal / Conference
Journal of Clinical Oncology 15(7):2494-2501
Year
1997
Research Committee(s)
Breast
Study Number(s)
SWOG-8312

Tamoxifen (T) versus cyclophosphamide, adriamycin and 5-FU plus either concurrent or sequential T in postmenopausal, receptor(+), node(+) breast cancer: a Southwest Oncology Group phase III intergroup trial (SWOG-8814, INT-0100).

Authors
K Albain;S Green;K Osborne;C Cobau;E Levine;J Ingle;K Pritchard;D Schneider;J O'Sullivan;E Hess;S Martino
Journal / Conference
Proc of the American Society of Clinical Oncology 16:128a(#450)
Year
1997
Research Committee(s)
Breast
Study Number(s)
SWOG-8814

Concurrent cisplatin/etoposide plus radiotherapy (PE+RT) for pathologic stage (pathTN) IIIB non-small cell lung cancer(NSCLC): a Southwest Oncology Group (SWOG) phase II study (S9019).

Authors
KS Albain;JJ Crowley;AT Turrisi III;DR Gandara;WB Farrar;J Clark;KR Beasley;RB Livingston
Journal / Conference
Proc of the American Society of Clinical Oncology 16:446a(#1600)
Year
1997
Research Committee(s)
Lung
Study Number(s)
SWOG-9019

Alpha interferon plus alternate day prednisone (IFN/P) improves remission maintenance duration in multiple myeloma (MM) compared to IFN alone.

Authors
SE Salmon;JJ Crowley
Journal / Conference
Proc of the American Society of Clinical Oncology 16:13a(#46)
Year
1997
Research Committee(s)
Myeloma
Study Number(s)
SWOG-9028

A randomized phase II trial of 13-cis-retinoic acid (CRA) or all-trans-retinoic acid (ATRA) plus interferon alpha 2a (IFN) for metastatic or recurrent squamous/adenosquamous carcinoma of the uterine cervix: a Southwest Oncology Group study

Authors
GR Weiss;PY Liu;DS Alberts;DR Gandara;LH Baker;HE Hynes
Journal / Conference
Proc of the American Society of Clinical Oncology 16:355a(#1268)
Year
1997
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9132

Phase II trial of all-trans-retinoic acid (RA) plus alpha interferon (IFN) in stage IV melanoma (SWOG 9223).

Authors
F Meyskens;V Sondak;PY Liu
Journal / Conference
Proc of the American Society of Clinical Oncology 16:491a(#1768)
Year
1997
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9223

Effects of anticonvulsants (ACs) on the pharmacokinetics (PK) and metabolic profile of paclitaxel.

Authors
J Kuhn;J Rizzo;S Chang;C Schold;A Spence;M Berger;H Robins;M Mehta;M Bozik;D Fulton;D Rector;M Prados
Journal / Conference
Proc of the American Society of Clinical Oncology 16:224a(#787)
Year
1997
Research Committee(s)
Brain
Study Number(s)
SWOG-9436 (NABTC-9403) (NCI T94-0184)